Klaus Lieb How Prevalent is Conflict of Interest in the Medical Profession?

Klaus Lieb is Chair of the Department of Psychiatry and Psychotherapy at the University Medical Center, Mainz and Managing Director of the German Resilience Center (DRZ). His main research interests include clinical resilience research and cognitive enhancement and conflicts of interest in medical practice and research. A member of the Drug Commission of the German Medical Association (DCGMA), Lieb is the author of several books including Conflicts of Interest, Corruption and Compliance in the Health Service (MWV, 2018). The recipient of a Golden Helix award in 2004, Lieb was awarded the Hamburger Prize for his work on Personality Disorders in 2013.

Area of Research

Therapy response prediction in affective disorders; Clinical resilience research and cognitive enhancement; Systematic reviews and metaanalyses; Conflicts of interests in clinic and research

since 2017

Managing Director

German Resilience Centre (Deutsches Resilienz Zentrum)

since 2014

Deputy Speaker

German Resilience Centre (Deutsches Resilienz Zentrum)

since 2007

Director and Chair

Johannes Gutenberg University of Mainz (Johannes Gutenberg-Universität Mainz)

Department of Psychiatry and Psychotherapy

2001-2007

Vice Chair

Albert Ludwigs University of Freiburg (Albert-Ludwigs-Universität Freiburg)

Department of Psychiatry and Psychotherapy

1999

Habilitation and „Venia legendi“ in Psychiatry

Albert Ludwigs University of Freiburg (Albert-Ludwigs-Universität Freiburg)

Faculty of Medicine

1994-1999

Research Assistant and Junior Doctor

Albert Ludwigs University of Freiburg (Albert-Ludwigs-Universität Freiburg)

Department of Psychiatry and Psychotherapy, Department of Neurology

1992-1994

Doctor in Training and Research Assistant

University of Ulm (Universität Ulm)

Departments of Internal Medicine and Anatomy and Cell Biology

1992

Dr. med., M.D.

University of Ulm (Universität Ulm)

1985-1992

Studies of Medicine and Philosophy

University of Ulm (Universität Ulm)

& Universities of Tübingen and Los Angeles

- Editor, Cochrane Developmental, Psychosocial and Learning Problems Group (CDPLPG)

- Editor, InFo Neurologie und Psychiatrie

- Member, Arzneimittelkommission der Deutschen Ärzteschaft

Prizes

- Hochschullehrer des Jahres (Deutscher Hochschulverband, 2013)

- Hamburger Prize Personality Disorders (2013)

- Golden Helix Award (2004)

- Hormosan-Forschungspreis Psychiatrie (2003)

Allegiance to a particular form of therapy or financial ties to a pharmaceutical company are among the phenomena that can undermine a physician’s primary goal, to provide the best possible treatment for his or her patients. In this video, KLAUS LIEB explores the ways in which conflicts of interest occur for both physicians and medical researchers before providing some suggestions as to how they might be avoided. Employing methods including surveys, systematic reviews and a randomized controlled trial, Lieb finds that conflict of interest has a notable influence in several of the areas studied. Demonstrating that educating medical students about the dangers of conflict of interest can go a long way towards reducing its impact, Lieb’s work provides important food for thought for physicians, medical researchers and regulatory bodies.

LT Video Publication DOI: https://doi.org/10.21036/LTPUB10747

Medical Students’ Attitudes to and Contact with the Pharmaceutical Industry: A Survey at Eight German University Hospitals

  • Klaus Lieb and Cora Koch
  • Deutsches Ärzteblatt International
  • Published in 2013
Klaus Lieb and Cora Koch. "Medical Students’ Attitudes to and Contact with the Pharmaceutical Industry: A Survey at Eight German University Hospitals." Deutsches Ärzteblatt International 110 (2013): 584. doi:10.3238/arztebl.2013.0584.

A Survey of German Physicians in Private Practice about Contacts with Pharmaceutical Sales Representatives

  • Klaus Lieb and Simone Brandtönies
  • Deutsches Ärzteblatt International
  • Published in 2010
Klaus Lieb and Simone Brandtönies. "A Survey of German Physicians in Private Practice about Contacts with Pharmaceutical Sales Representatives." Deutsches Ärzteblatt International 107 (2010): 392. doi:10.3238/arztebl.2010.0392.

Contact Between Doctors and the Pharmaceutical Industry, their Perceptions, and the Effects on Prescribing Habits

  • Klaus Lieb and Armin Scheurich
  • PloS One
  • Published in 2014
Klaus Lieb and Armin Scheurich. "Contact Between Doctors and the Pharmaceutical Industry, their Perceptions, and the Effects on Prescribing Habits." PloS One 9 (2014): e110130. doi:10.1371/journal.pone.0110130.

The Financing of Drug Trials by Pharmaceutical Companies and its Consequences: Part 1: A Qualitative, Systematic Review of the Literature on Possible Influences on the Findings, Protocols, and Quality of Drug Trials

  • Gisela Schott, Henry Pachl, Ulrich Limbach, Ursula Gundert-Remy, Wolf-Dieter Ludwig and Klaus Lieb
  • Deutsches Ärzteblatt International
  • Published in 2010
Gisela Schott, Henry Pachl, Ulrich Limbach, Ursula Gundert-Remy, Wolf-Dieter Ludwig and Klaus Lieb. "The Financing of Drug Trials by Pharmaceutical Companies and its Consequences: Part 1: A Qualitative, Systematic Review of the Literature on Possible Influences on the Findings, Protocols, and Quality of Drug Trials." Deutsches Ärzteblatt International 107 (2010): 279. doi:10.3238/arztebl.2010.0279.

The Financing of Drug Trials by Pharmaceutical Companies and its Consequences: Part 2: A Qualitative, Systematic Review of the Literature on Possible Influences on Authorship, Access to trial data, and Trial Registration and Publication

  • Gisela Schott, Henry Pachl, Ulrich Limbach, Ursula Gundert-Remy, Klaus Lieb and Wolf-Dieter Ludwig
  • Deutsches Ärzteblatt International
  • Published in 2010
Gisela Schott, Henry Pachl, Ulrich Limbach, Ursula Gundert-Remy, Klaus Lieb and Wolf-Dieter Ludwig. "The Financing of Drug Trials by Pharmaceutical Companies and its Consequences: Part 2: A Qualitative, Systematic Review of the Literature on Possible Influences on Authorship, Access to trial data, and Trial Registration and Publication." Deutsches Ärzteblatt International 107 (2010): 295. doi:10.3238/arztebl.2010.0295.

Conflicts of Interest and Spin in Reviews of Psychological Therapies: A Systematic Review

  • Klaus Lieb, Jan von der Osten-Sacken, Jutta Stoffers-Winterling, Neele Reiss and Jürgen Barth
  • BMJ Open
  • Published in 2016
Klaus Lieb, Jan von der Osten-Sacken, Jutta Stoffers-Winterling, Neele Reiss and Jürgen Barth. "Conflicts of Interest and Spin in Reviews of Psychological Therapies: A Systematic Review." BMJ Open 6 (2016): e010606. doi:10.1136/bmjopen-2015-010606.

Interessenkonflikte Korruption und Compliance im Gesundheitswesen

  • Published in 2018
K. Lieb, D. Klemperer, R. Kölbel and W.D. Ludwig (Eds.). Interessenkonflikte Korruption und Compliance im Gesundheitswesen. Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft, 2018.